QIMA completed the acquisition of OxiProteomics.

QIMA, a company which provides quality control, supply chain audits, product testing, and compliance services for various industries, completed the acquisition of OxiProteomics, company which is specialized in biomarkers discovery. Financial terms were not disclosed. With this acquisition, QIMA reaffirms its commitment to advancing innovation in the cosmetics, pharmaceutical, and biotechnology industries, and to providing comprehensive support from preclinical to clinical development.